Dr. Wood is Professor of Laboratory Medicine and Pathology at the University of Washington in Seattle where he is Division Head for the Hematopathology Laboratory and Medical Director of Laboratories at the Seattle Cancer Care Alliance. Flow cytometry and minimal residual disease detection have been areas of particular interest for Dr. Wood.  He was responsible for implementing the first use of 10 color flow cytometry in the clinical laboratory and exploiting its potential for the identification of minimal residual disease in acute lymphoid and myeloid leukemia. He also was involved in the first demonstration of next generation sequencing for the detection of residual acute leukemia. His laboratory serves as one of two national reference laboratories for the identification of minimal residual disease in childhood acute lymphoblastic leukemia for the Children’s Oncology Group, serves a similar function for the Southwest Oncology Group, and provides immunophenotyping services for many biopharma companies.  Dr. Wood is Past President of the International Clinical Cytometry Society and lectures extensively both nationally and internationally on clinical applications of flow cytometry.